26 March 2020
DBL Pharmaceutical Inc. an American concern of Bangladeshi DBL Group, has achieved notable success in the generic drug market of the United States. In the last quarter, the company was named as the second largest seller of muscle relaxant “Methocarbamol” tablets, according to a recent report by IQVIA – an American health and clinical research company. The market report says, among the 13 generic drug companies selling Methocarbamol in the US, DBL Pharma holds 14.20 percent of the market share.
Methocarbamol is a widely used medicine to treat muscle pain in the US. After the expiration of the proprietary patent of the first marketer of this medicine, mostly Indian generic medicine companies started occupying the market share. By the end of 2018, DBL Group of Bangladesh got approval of the US Food and Drug Administration (FDA) to market this medicine in the United States.
In the first quarter of 2019, DBL Pharma Inc. the concern of DBL group started marketing in America after purchasing the propriety of two generic medicines of the FDA-approved Methocarbamol through contract manufacturing. DBL started with a surprise, as the third Bangladeshi initiative in the US medicine market.
DBL Pharma is hopeful of exporting medicines to other developed countries in future as well to carry forward the thrive for exploring new opportunities.
DBL pharma recently unveiled Seretrol-F Sykonahaler, which is a technologically advanced Multi-Dose Dry Powder Inhaler. This device will ensure precise treatment for the management of Asthma & COPD and overcome the limitation of the conventional devices. The grand launching event is endorsed by Bangladesh Lung Foundation (BLF) and held at Sheraton Banani, Dhaka on 05… Continue reading DBL pharma launches Seretrol-F Sykonahaler
DBL Pharmaceuticals Ltd. convened its highly anticipated 2nd Annual Business Conference at the prestigious Hotel Sea Palace. The event served as a pivotal moment for DBL Pharma, rallying its dedicated field force around a shared commitment to delivering unparalleled quality and innovative medicines to humanity. The conference was inaugurated by Mr. Abdul Wahed, Chairman, DBL… Continue reading DBL Pharma Hosts 2nd Annual Business Conference
DBL Pharma celebrates 3rd Annual Business Conference with Vision to Victory
DBL Pharmaceuticals Ltd. hosted its 3rd Annual Business Conference on January 11, 2025, at Cox’s Bazar. The event brought together the company’s sales & marketing team along with key stakeholders to discuss its mission of providing high-quality and innovative medicines for better healthcare. The Board of Directors including Chairman Mr. Abdul Wahed, Managing Director Mr.… Continue reading DBL Pharma celebrates 3rd Annual Business Conference with Vision to Victory